Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea · Delayed Price · Currency is KRW 90,100
+200 (0.22%)
At close: Apr 16, 2026
Chong Kun Dang Pharmaceutical Company Description
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally.
It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements.
The company was founded in 1941 and is headquartered in Seoul, South Korea.
Chong Kun Dang Pharmaceutical Corp.
| Country | South Korea |
| Founded | 1941 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,253 |
| CEO | Young-Joo Kim |
Contact Details
Address: Chong Kun Dang Building Seoul South Korea | |
| Phone | 82 2 2194 0300 |
| Website | ckdpharm.com |
Stock Details
| Ticker Symbol | 185750 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7185750007 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Young-Joo Kim | President, Chief Executive Officer and Chairman |
| Dong-ha Lee | Finance Manager and Director |